West Pharmaceutical Services, Inc.
WST
Key stats
- Open
- 411.39
- Day high
- 415.90
- Day low
- 406.69
- Previous close
- 412.86
- Volume
- 378.1K
- VWAP
- 411.97
- 52-week high
- 438.27
- 52-week low
- 223.83
- Market cap
- 28.76B
- Shares out
- 69.66M
- Employees
- 10,800
- Listed
- 1973
About West Pharmaceutical Services, Inc.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · EXTON, PA · westpharma.com
Options · expiring Nov 20
Nov 12, 4:00 PM ET- Call open interest
- 895
- Put open interest
- 322
- Put/call
- 0.36
- At-the-money IV
- 31.3%
| Contract | Last | Traded | Volume | Open int. | IV |
|---|---|---|---|---|---|
| 420 put | 26.70 | Nov 5, 3:29 PM | 90 | 24 | 25.5% |
| 460 put | 49.70 | Oct 30, 11:26 AM | 70 | 22 | — |
| 410 call | 10.90 | Nov 10, 1:53 PM | 17 | 60 | 31.3% |
| 360 call | 65.95 | Oct 29, 9:49 AM | 11 | 4 | 55.2% |
| 330 put | 0.50 | Nov 5, 9:57 AM | 10 | 10 | 86.5% |
| 370 put | 0.70 | Nov 9, 1:47 PM | 6 | 45 | 48.3% |
Quarterly results
Massive · Oct 29, 2026| Q3 2026 to Sep 30, 2026 | Q2 2026 to Jun 30, 2026 | Q1 2026 to Mar 31, 2026 | Q4 2025 to Dec 31, 2025 | |
|---|---|---|---|---|
| Revenue | $874.50M | $872.30M | $844.90M | $805.00M |
| Gross profit | $347.40M | $329.20M | $296.40M | $303.90M |
| Operating income | $216.20M | $191.90M | $181.10M | $175.10M |
| Net income | $214.00M | $154.00M | $138.80M | $132.10M |
| Diluted EPS | 3.02 | 2.15 | 1.92 | 1.82 |
| Operating cash flow | $189.50M | $124.00M | $89.90M | $251.10M |
| Assets | $4.06B | $4.08B | $4.11B | $4.27B |
| Liabilities | $1.09B | $1.09B | $1.12B | $1.09B |
| Equity | $2.97B | $2.99B | $2.99B | $3.18B |
Technicals
Massive · Nov 12, 2026- 50-day average378.70
- 200-day average320.47
- RSI (14 days)62.9
Short interest
Massive · Oct 30, 2026- Oct 30, 20261.81M shares · 2.3 days to cover
- Oct 15, 20262.01M shares · 4.2 days to cover
- Sep 30, 20262.10M shares · 3.1 days to cover
- Sep 15, 20262.38M shares · 4.5 days to cover
Dividends
Massive · Nov 10, 2026- Ex Nov 10, 2026, paid Nov 18, 20260.2600 · 4 a year
- Ex Jul 29, 2026, paid Aug 5, 20260.2200 · 4 a year
- Ex Apr 29, 2026, paid May 6, 20260.2200 · 4 a year
- Ex Jan 28, 2026, paid Feb 4, 20260.2200 · 4 a year
- Ex Nov 12, 2025, paid Nov 19, 20250.2200 · 4 a year
- Ex Jul 30, 2025, paid Aug 6, 20250.2100 · 4 a year
- Ex Apr 30, 2025, paid May 7, 20250.2100 · 4 a year
- Ex Feb 7, 2025, paid Feb 11, 20250.2100 · 4 a year
Splits
Massive · Sep 27, 2013- Sep 27, 20132-for-1
- Sep 30, 20042-for-1
Related companies
MassiveNews coverage
No stories about West Pharmaceutical Services, Inc. right now.